Myopia Control With a Innovative Spectacle Lens

NCT05174780 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 159

Last updated 2025-12-22

No results posted yet for this study

Summary

The purpose of this study is to demonstrate that the test spectacle lens is safe and effective in slowing myopia progression in children.

Conditions

  • Myopia

Interventions

DEVICE

innovative myopia control spectacle lens

using a innovative spectacle lens to control myopia progression

DEVICE

Single vision spectacle lens

single vision spectacle lens for myopia and astigmatism correction

Sponsors & Collaborators

  • Essilor International

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
6 Years
Max Age
12 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-12-29
Primary Completion
2025-10-20
Completion
2025-10-20
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05174780 on ClinicalTrials.gov